VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
MTU Aero Engines AG vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
MTU Aero Engines AG
MTX · Deutsche Boerse XETRA
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into MTU Aero Engines AG's moat claims, evidence, and risks.
View MTX analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 61 / 100 for MTU Aero Engines AG).
- Segment focus: MTU Aero Engines AG has 2 segments (67.4% in MRO business (commercial maintenance)); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: MTU Aero Engines AG has 8 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
MTU Aero Engines AG
MRO business (commercial maintenance)
Commercial aircraft engine maintenance, repair and overhaul (engine MRO) and associated services
Global
Airlines, lessors and engine owners/operators
Aftermarket service provider (engine shop visits, repairs, on-wing services, leasing/asset management)
67.4%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
MTU Aero Engines AG strengths
Sanofi strengths
Segment mix
MTU Aero Engines AG segments
Full profile >OEM business (commercial and military engine business)
Oligopoly
MRO business (commercial maintenance)
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.